BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 21880832)

  • 21. Inhibition of tissue angiotensin converting enzyme by perindopril: in vivo assessment in the rat using radioinhibitor binding displacement.
    Jackson B; Cubela RB; Johnston CI
    J Pharmacol Exp Ther; 1988 Jun; 245(3):950-5. PubMed ID: 2838609
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Neuroprotective effect of the angiotensin-converting enzyme inhibitor perindopril in MPTP-treated mice.
    Kurosaki R; Muramatsu Y; Imai Y; Kato H; Araki T
    Neurol Res; 2004 Sep; 26(6):644-57. PubMed ID: 15327754
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Therapeutic modulation of the nitric oxide: all ace inhibitors are not equivalent.
    Comini L; Bachetti T; Cargnoni A; Bastianon D; Gitti GL; Ceconi C; Ferrari R
    Pharmacol Res; 2007 Jul; 56(1):42-8. PubMed ID: 17475504
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effects of perindopril on angiotensin converting enzyme in tissues of the rat.
    Jackson B; Cubela RB; Johnston CI
    J Hypertens Suppl; 1988 Dec; 6(3):S51-4. PubMed ID: 2852236
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Divergent effects of angiotensin-converting enzyme inhibition on blood pressure and endothelial function in obese humans.
    Williams IL; Chowienczyk PJ; Wheatcroft SB; Patel AG; Sherwood RA; Shah AM; Kearney MT
    Diab Vasc Dis Res; 2006 May; 3(1):34-8. PubMed ID: 16784179
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The effect of perindopril and enalapril on plasma resistin levels in normotensive patients with coronary heart disease.
    Krysiak R; Sierant M; Marek B; Okopień B
    Endokrynol Pol; 2010; 61(6):683-90. PubMed ID: 21104642
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Upregulation of angiotensin-converting enzyme (ACE) 2 in hepatic fibrosis by ACE inhibitors.
    Huang ML; Li X; Meng Y; Xiao B; Ma Q; Ying SS; Wu PS; Zhang ZS
    Clin Exp Pharmacol Physiol; 2010 Jan; 37(1):e1-6. PubMed ID: 19793108
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Central angiotensin converting enzyme facilitates memory impairment in intracerebroventricular streptozotocin treated rats.
    Tota S; Kamat PK; Saxena G; Hanif K; Najmi AK; Nath C
    Behav Brain Res; 2012 Jan; 226(1):317-30. PubMed ID: 21864581
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Inhibition of central angiotensin converting enzyme ameliorates scopolamine induced memory impairment in mice: role of cholinergic neurotransmission, cerebral blood flow and brain energy metabolism.
    Tota S; Nath C; Najmi AK; Shukla R; Hanif K
    Behav Brain Res; 2012 Jun; 232(1):66-76. PubMed ID: 22460064
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Angiotensin-converting enzyme inhibition in cardiovascular disease: evidence with perindopril.
    Ferrari R
    Expert Rev Cardiovasc Ther; 2005 Jan; 3(1):15-29. PubMed ID: 15723572
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Perindopril, an angiotensin converting enzyme inhibitor, in pulmonary hypertensive rats: comparative effects on pulmonary vascular structure and function.
    Jeffery TK; Wanstall JC
    Br J Pharmacol; 1999 Dec; 128(7):1407-18. PubMed ID: 10602319
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Metabolic effects of low dose angiotensin converting enzyme inhibitor in dietary obesity in the rat.
    Velkoska E; Warner FJ; Cole TJ; Smith I; Morris MJ
    Nutr Metab Cardiovasc Dis; 2010 Jan; 20(1):49-55. PubMed ID: 19361967
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Chronic reduction of nitric oxide level in adult spontaneously hypertensive rats induces aortic stiffness similar to old spontaneously hypertensive rats.
    Isabelle M; Simonet S; Ragonnet C; Sansilvestri-Morel P; Clavreul N; Vayssettes-Courchay C; Verbeuren TJ
    J Vasc Res; 2012; 49(4):309-18. PubMed ID: 22572574
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The effect of treatment with low dose ACE inhibitor and/or diuretic on coronary microvasculature in stroke-prone spontaneously hypertensive rats.
    Rakusan K; Cicutti N; Maurin A; Guez D; Schiavi P
    Microvasc Res; 2000 Mar; 59(2):243-54. PubMed ID: 10684730
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Perindopril chronically inhibits angiotensin-converting enzyme in both the endothelium and adventitia of the internal mammary artery in patients with ischemic heart disease.
    Zhuo JL; Froomes P; Casley D; Liu JJ; Murone C; Chai SY; Buxton B; Mendelsohn FA
    Circulation; 1997 Jul; 96(1):174-82. PubMed ID: 9236432
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Protective effect of perindopril on dysfunction of endothelium-dependent relaxation in diabetic rats].
    Liu SK; Chen X; You JL; Zhou M
    Hunan Yi Ke Da Xue Xue Bao; 2000 Apr; 25(2):122-4. PubMed ID: 12212195
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Altered angiotensin-converting enzyme and its effects on the brain in a rat model of Alzheimer disease.
    Hou DR; Wang Y; Zhou L; Chen K; Tian Y; Song Z; Bao J; Yang QD
    Chin Med J (Engl); 2008 Nov; 121(22):2320-3. PubMed ID: 19080340
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effect of angiotensin-converting enzyme inhibitor perindopril on interneurons in MPTP-treated mice.
    Kurosaki R; Muramatsu Y; Kato H; Watanabe Y; Imai Y; Itoyama Y; Araki T
    Eur Neuropsychopharmacol; 2005 Jan; 15(1):57-67. PubMed ID: 15572274
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Administration of an angiotensin-converting enzyme inhibitor improves vascular function and urinary albumin excretion in low-risk essential hypertensive patients receiving anti-hypertensive treatment with calcium channel blockers. Organ-protecting effects independent of anti-hypertensive effect.
    Watanabe Y; Takasugi E; Shitakura K; Okajima K; Hota N; Kubo Y; Nunoda S; Otsuka K
    Clin Exp Hypertens; 2011; 33(4):246-54. PubMed ID: 21699451
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Functional and partial morphological regression of established renal injury in the obese zucker rat by blockade of the renin-angiotensin system.
    Sebeková K; Lill M; Boor P; Heidland A; Amann K
    Am J Nephrol; 2009; 29(3):164-70. PubMed ID: 18753741
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.